Advertisement
A total of 1,587,000 shares of common stock were issued in connection withthis offering and over-allotment exercise. After deducting underwritingdiscounts and commissions and other estimated offering expenses, WinnerMedical received aggregate net proceeds of approximately $8.8 million from thepublic offering, including net proceeds received from the over-allotmentexercise. Winner Medical intends to use the net proceeds from this offering toexpand the production capacity of its PurCotton(R) product line and forgeneral corporate and working capital purposes.
Advertisement
The shares were offered and sold under the Company's existing shelfregistration statement on form S-3, which was declared effective by theSecurities and Exchange Commission (the "SEC") on March 18, 2010. Copies ofthe final prospectus supplement and related prospectus may be obtained byvisiting EDGAR or the SEC Website at http://www.sec.gov or upon request fromRoth Capital Partners, LLC by e-mail to [email protected], by fax to+1-949-720-7227, or by mail to 24 Corporate Plaza Drive, Newport Beach, CA92660, Attention: Equity Capital Markets.
This press release shall not constitute an offer to sell or thesolicitation of an offer to buy any of the securities, nor shall there be anysale of these securities in any state or jurisdiction in which such offer,solicitation or sale would be unlawful prior to registration or qualificationunder the securities laws of any such state or jurisdiction.
About Winner Medical
Winner Medical is a leading manufacturer and the largest exporter byvolume in the medical dressing industry in China. Headquartered in Shenzhen,the Company has eight wholly-owned operating subsidiaries and four jointventures with over 5,000 employees. The Company engages in the manufacturing,sale, research, and development of medical care products, wound care products,home care products and PurCotton(R) products, a non-woven fabric made from100% natural cotton. The products are sold worldwide, with Europe, the UnitedStates, China and Japan serving as the top four markets. The Company currentlyholds more than sixty patents and patent applications for various products andmanufacturing processes and is one of the few Chinese companies licensed bythe U.S. Food and Drug Administration (FDA) to ship finished, sterilizedproducts directly to the United States market. To learn more about WinnerMedical, please visit Winner Medical's web site at:http://ir.winnermedical.com .
Forward-Looking Statements:
This press release contains certain statements that may include"forward-looking statements" within the meaning of Section 27A of theSecurities Act of 1933, as amended, and Section 21E of the Securities ExchangeAct of 1934, as amended. All statements, other than statements of historicalfact included herein are "forward-looking statements" including statementsregarding Winner Medical and its subsidiary companies' business strategy,plans and objective and statements of non-historical information. Theseforward-looking statements are often identified by the use of forward-lookingterminology such as "believes," "expects" or similar expressions, involveknown and unknown risks and uncertainties. Although Winner Medical believesthat the expectations reflected in these forward-looking statements arereasonable, they do involve assumptions, risks and uncertainties, and theseexpectations may prove to be incorrect. You should not place undue reliance onthese forward-looking statements, which speak only as of the date of thispress release. Winner Medical's actual results could differ materially fromthose anticipated in these forward- looking statements as a result of avariety of factors, including those discussed in Winner Medical's periodicreports that are filed with and available from the Securities and ExchangeCommission. All forward- looking statements attributable to Winner Medical orpersons acting on its behalf are expressly qualified in their entirety bythese factors. Other than as required under the securities laws, WinnerMedical does not assume a duty to update these forward-looking statements.For more information, please contact: Company: Peng Zhai Investor Relations Manager Winner Medical Group Inc. Tel: +86-755-2806-6858 +86-755-2813-8888 x691 Email: [email protected] Web: http://ir.winnermedical.com Investors: Scott Powell HC International, Inc. Tel: +1-917-721-9480 Email: [email protected] Web: http://www.hcinternational.net
SOURCE Winner Medical Group Inc.
